Literature DB >> 8331113

Chronic multifocal osteomyelitis.

A J Carr1, W G Cole, D M Roberton, C W Chow.   

Abstract

We describe 22 patients who presented between the ages of 4 and 14 years with gradual onset of malaise and pain at the sites of multiple bone lesions. The symptoms from the bone lesions were sometimes sequential in onset and often relapsing. The radiological findings were typical of osteomyelitis. Radioisotope bone scans identified some clinically silent lesions. Bone biopsies were performed in 20 patients and the changes of osteomyelitis were seen in 17; microbiological culture was positive in only one. Seven patients had polyarthritis, two had palmoplantar pustulosis and one had psoriasis. Some symptomatic relief was obtained with anti-inflammatory agents and, to a less extent, with antibiotics. No patient had primary immunodeficiency. The mean duration of symptoms from the bone lesions was two years (1 to 4). When arthritis was present the joint symptoms lasted considerably longer (mean 7 years; range 4 to 10). The long-term prognosis was generally good. There was no evidence of altered bone growth or abnormal joint development. One patient developed a progressive kyphosis requiring fusion, but no other surgical intervention was necessary.

Entities:  

Mesh:

Year:  1993        PMID: 8331113

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  22 in total

1.  Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children.

Authors:  A Bousvaros; M Marcon; W Treem; P Waters; R Issenman; R Couper; R Burnell; A Rosenberg; E Rabinovich; B S Kirschner
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.

Authors:  Toni Hospach; Micha Langendoerfer; Tekla von Kalle; Jan Maier; Guenther E Dannecker
Journal:  Eur J Pediatr       Date:  2010-03-27       Impact factor: 3.183

3.  Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children.

Authors:  A Schnabel; U Range; G Hahn; T Siepmann; R Berner; C M Hedrich
Journal:  Rheumatol Int       Date:  2016-10-11       Impact factor: 2.631

4.  Complete resolution and remodeling of chronic recurrent multifocal osteomyelitis on MRI and radiographs.

Authors:  Y J Berkowitz; S J Greenwood; G Cribb; K Davies; V N Cassar-Pullicino
Journal:  Skeletal Radiol       Date:  2017-11-09       Impact factor: 2.199

Review 5.  New discoveries in CRMO: IL-1β, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice.

Authors:  Polly J Ferguson; Ronald M Laxer
Journal:  Semin Immunopathol       Date:  2015-04-17       Impact factor: 9.623

Review 6.  Chronic non-bacterial osteomyelitis and autoinflammatory bone diseases.

Authors:  Yongdong Zhao; Polly J Ferguson
Journal:  Clin Immunol       Date:  2020-05-07       Impact factor: 3.969

Review 7.  Chronic recurrent multifocal osteomyelitis involving the mandible: case reports and review of the literature.

Authors:  P A J Monsour; J B Dalton
Journal:  Dentomaxillofac Radiol       Date:  2010-03       Impact factor: 2.419

8.  A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis.

Authors:  Polly J Ferguson; Xinyu Bing; Mohammed A Vasef; Luis A Ochoa; Amar Mahgoub; Thomas J Waldschmidt; Lorraine T Tygrett; Annette J Schlueter; Hatem El-Shanti
Journal:  Bone       Date:  2005-08-24       Impact factor: 4.398

9.  Imaging of chronic recurrent multifocal osteomyelitis of childhood first presenting with isolated primary spinal involvement.

Authors:  S E Anderson; P Heini; M J Sauvain; E Stauffer; L Geiger; J O Johnston; A Roggo; D Kalbermatten; L S Steinbach
Journal:  Skeletal Radiol       Date:  2003-02-21       Impact factor: 2.199

Review 10.  Chronic recurrent multifocal osteomyelitis.

Authors:  Patrícia Costa-Reis; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2013-05-22       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.